Lifesaving Lincoln Laboratory device wins 2026 Excellence in Technology Transfer Award

The Federal Laboratory Consortium (FLC) selected AI-GUIDE, a medical device developed by MIT Lincoln Laboratory and Massachusetts General Hospital (MGH), for its 2026 Excellence in Technology Transfer Award. This award recognizes federal laboratories and collaborators who have accomplished outstanding work in the process of transferring technology. With funding from the U.S. Army's Combat Casualty Care Research Program (CCC), Lincoln Laboratory and MGH developed AI-GUIDE and are in the process of transferring the prototype to the startup company AutonomUS Medical Technologies, Inc.

"This recognition reflects what effective technology transfer looks like — aligning the Army's operational need with Mass General's clinical expertise and Lincoln Laboratory's engineering capabilities to deliver a solution with a clear path to impact. The transition to AutonomUS underscores how strong partnerships can carry a technology from development into real-world adoption," says Asha Rajagopal, Lincoln Laboratory's chief technology transfer officer. 

AI-GUIDE's transition to industry promises improved health outcomes for injured service members and civilians. Unlike ultrasound devices typically found in hospitals, AI-GUIDE is small and portable, making it ideal for use in pre-hospital settings. Pairing custom-developed AI software with commercial handheld ultrasound technology, AI-GUIDE helps the user insert a guidewire and catheter into a patient's blood vessel. This capability is especially important for U.S. military medics, who must keep injured soldiers alive in the field — sometimes for days — before they can be evacuated to a hospital. AI-GUIDE allows medics with minimal specialized training to administer medical interventions that would otherwise be impossible outside of the hospital, drastically improving patients’ chances of survival.